Active cytomegalovirus retinitis after the start of antiretroviral therapy

Autor: W L Drew, Gary N. Holland, F N Smithuis, Jeremy D. Keenan, Catherine E. Oldenburg, N Tun, David Heiden
Rok vydání: 2018
Předmět:
CD4-Positive T-Lymphocytes
Male
Pediatrics
Visual Acuity
Ophthalmology & Optometry
0302 clinical medicine
Antiretroviral Therapy
Highly Active

AIDS-related opportunistic infections
virus diseases
Sensory Systems
Indirect ophthalmoscopy
eye examination in AIDS
Infectious Diseases
6.1 Pharmaceuticals
Cytomegalovirus Retinitis
Public Health and Health Services
HIV/AIDS
Female
Cytomegalovirus retinitis
Infection
Adult
Cart
medicine.medical_specialty
AIDS-Related Opportunistic Infections
Clinical Sciences
Congenital cytomegalovirus infection
Antiretroviral Therapy
Retinitis
Delayed diagnosis
Antiviral Agents
Article
diagnosis CMV retinitis
03 medical and health sciences
Cellular and Molecular Neuroscience
Opthalmology and Optometry
medicine
Humans
Highly Active
treatment CMV retinitis
cytomegalovirus
Retrospective Studies
business.industry
Evaluation of treatments and therapeutic interventions
medicine.disease
Antiretroviral therapy
CD4 Lymphocyte Count
Ophthalmoscopy
Ophthalmology
Cross-Sectional Studies
CMV retinitis
030221 ophthalmology & optometry
business
030217 neurology & neurosurgery
Zdroj: The British journal of ophthalmology, vol 103, iss 2
Br J Ophthalmol
Popis: Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART.
Databáze: OpenAIRE